Abstract

The current model of binding of the antitumor antibiotic olivomycin A (1) to GC-rich DNA regions presumes that coordination of the magnesium divalent cation with drug dimers is necessary for binding of 1 into the minor groove of the DNA duplex. Previously we have synthesized the derivatives of 1 termed ‘short acid’ (2) and its N,N-dimethylaminoethylamide (3). The latter compound demonstrated an improved tolerance in vivo compared to 1 and good therapeutic potency in animal models. We herein report that compound 3 is able to form stable complexes with DNA in the absence of Mg2+, in striking contrast to 1 whose binding to the DNA absolutely requires Mg2+. The mode of binding of 3 to DNA is similar in the presence or absence of Mg2+ as determined by circular dichroism. The affinity to DNA of 3 in Mg2+-free solution was similar to that of 1 or 3 in the presence of Mg2+ at low ionic strength. Non-electrostatic contributions to total free energy of binding of 1 and 3 to DNA were comparable for Mg2+-free complexes. Our data strongly suggest that electrostatic interaction of the positively charged 3 can compensate for the absence of divalent ions in complexes with DNA. This new property of the olivomycin A derivative expands the mechanistic knowledge of the modes of interaction with DNA of small molecular weight drug candidates.

Highlights

  • The aureolic acid family of antibiotics has long been considered a class of antitumor drug candidates

  • We studied the binding of olivomycin A and its structurally close derivatives 2 and 3 (Fig 1) to calf thymus DNA (ctDNA) by two independent methods: gel migration and fluorescence

  • Staining of the same gel with ethidium bromide (EtBr) and subsequent UV visualization (Fig 2A, bottom panel) revealed a slightly retarded migration of DNA in complexes with 1 and 3 compared to free DNA, while no retardation was detectable after incubation of the plasmid with 2

Read more

Summary

Introduction

The aureolic acid family of antibiotics (chromomycin A3, mithramycin and olivomycin A) has long been considered a class of antitumor drug candidates. We report that divalent cations are not required for the formation of stable complexes between the positively charged olivomycin A derivative 3 and DNA.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.